clofarabine has been researched along with Hematologic Malignancies in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Abou Dalle, I; Atoui, A; Bazarbachi, A; Bidaoui, G; Dulery, R; El Cheikh, J; Mohty, M; Moukalled, N; Sharrouf, L; Terro, K; Zahreddine, A | 1 |
| Cross, SJ; Geiger, T; Inaba, H; Jeha, S; Kang, G; Sharma, A; Sunkara, A; Triplett, B | 1 |
| Dvorak, CC; Huang, L; Ivaturi, V; Jones, AK; Long-Boyle, J; Orchard, P; Wang, H | 1 |
| Artz, AS; Cao, H; Hard, M; O'Donnell, PH; Petri, CR; Stock, W; van Besien, K; Wickrema, A | 1 |
| Korycka, A; Lech-Marańda, E; Robak, T | 2 |
| Albertioni, F; Juliusson, G; Lotfi, K; Zhenchuk, A | 1 |
| Andersson, BS; Valdez, BC | 1 |
| Baleydier, F; Domenech, C; Thomas, X | 1 |
| Bhojwani, D; Campana, D; Cheng, C; Howard, SC; Inaba, H; Jeha, S; Leung, W; Metzger, ML; Pauley, JL; Pei, D; Pui, CH; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
| Artz, AS; Del Cerro, P; Godley, LA; Kline, J; Larson, RA; Nguyen, V; O'Donnell, PH; Odenike, O; Rich, E; Stock, W; van Besien, K | 1 |
| Claxton, D; Ehmann, WC; Karch, J; Zhu, J | 1 |
| Bashir, Q; Bayraktar, UD; Champlin, RE; Ciurea, SO; Qazilbash, M | 1 |
| Cheson, BD | 1 |
| Cortes, J; Du, M; Faderl, S; Gandhi, V; Giles, F; Ibrahim, N; Jeha, S; Kantarjian, HM; Keating, M; Khuri, F; Kozuch, P; McLaughlin, P; O'Brien, S; Plunkett, W; Rios, MB | 1 |
| Faderl, S; Gandhi, V; Jeha, S; Kantarjian, HM; Keating, MJ; Plunkett, W | 1 |
8 review(s) available for clofarabine and Hematologic Malignancies
| Article | Year |
|---|---|
Novel purine nucleoside analogues for hematological malignancies.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Hematologic Neoplasms; Humans; Purine Nucleosides; Pyrimidinones | 2008 |
Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Hematologic Neoplasms; Humans; Nucleosides | 2009 |
Mechanisms of anti-cancer action and pharmacology of clofarabine.
Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neoplasms | 2009 |
Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Busulfan; Clofarabine; Cross-Linking Reagents; Hematologic Neoplasms; Humans; Preoperative Care; Stem Cell Transplantation; Vidarabine | 2010 |
[Novel conventional therapies in onco-hemathology].
Topics: Adenine Nucleotides; Antibodies, Monoclonal; Antineoplastic Agents; Arabinonucleosides; Chemistry, Pharmaceutical; Clofarabine; Hematologic Neoplasms; Humans; Molecular Targeted Therapy; Purine Nucleosides; Pyrimidinones | 2011 |
Fifty years of melphalan use in hematopoietic stem cell transplantation.
Topics: Adenine Nucleotides; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Boronic Acids; Bortezomib; Clofarabine; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Melphalan; Multiple Myeloma; Myeloablative Agonists; Pyrazines; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous | 2013 |
Hematologic malignancies: new developments and future treatments.
Topics: Adenine Nucleotides; Alemtuzumab; Alkaloids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Apoptosis; Arabinonucleosides; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Cell Cycle; Cell Survival; Clofarabine; Cytosine; Dioxolanes; Flavonoids; Hematologic Neoplasms; Humans; Immunoconjugates; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Multiple Myeloma; NF-kappa B; Nitrogen Mustard Compounds; Oligonucleotides, Antisense; Peptide Hydrolases; Piperidines; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Remission Induction; Rituximab; Staurosporine; Thionucleotides | 2002 |
The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Agents; Arabinonucleosides; Child; Clofarabine; Hematologic Neoplasms; Humans; Leukemia; Lymphoproliferative Disorders; Neoplasms | 2005 |
5 trial(s) available for clofarabine and Hematologic Malignancies
| Article | Year |
|---|---|
Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms.
Topics: Adolescent; Allografts; Child; Child, Preschool; Clofarabine; Disease-Free Survival; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Risk Factors; Survival Rate; Transplantation Conditioning | 2018 |
Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation.
Topics: Adolescent; Allografts; Child; Child, Preschool; Clofarabine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Models, Biological; Transplantation Conditioning | 2019 |
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adenine Nucleotides; Adult; Age Factors; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Female; Glomerular Filtration Rate; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Recurrence; Risk; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Clofarabine and CY do not yield reliable engraftment of hematopoietic stem cells.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Cyclosporine; Female; Graft Survival; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Peripheral Blood Stem Cell Transplantation; Transplantation, Homologous | 2012 |
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Agents; Arabinonucleosides; Bone Marrow; Breast Neoplasms; Clofarabine; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Hematologic Neoplasms; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Liver; Lung Neoplasms; Male; Middle Aged; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2003 |
3 other study(ies) available for clofarabine and Hematologic Malignancies
| Article | Year |
|---|---|
Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective cohort study.
Topics: Adult; Aged; Clofarabine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Middle Aged; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation; Young Adult | 2023 |
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.
Topics: Acute Kidney Injury; Adenine Nucleotides; Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleosides; Area Under Curve; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clofarabine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Kidney Function Tests; Male; Middle Aged; Prognosis; Risk Factors; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous | 2014 |
Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.
Topics: Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Female; Hematologic Neoplasms; Humans; Infant; Male | 2012 |